Pavani Ellipeddi, MD
Medical Oncology · Baton Rouge, LANPI 1194905737
Payments from drug & device makers
Across 521 payments — averaging $24.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$2K
- Novartis$975
- AstraZeneca$964
- Merck$694
- Pfizer$470
- Astellas Pharma US Inc$434
- plus $7K from 54 others
Across 2 payments — averaging $1064.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
Too few medical oncology providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Baton Rouge
- Michael CastineBaton Rouge$2.7M
- Gerald MiletelloBaton Rouge$327K
- Cody MillimanBaton Rouge$7K
- Constance BluntBaton Rouge$4K
- Laura FinnNew Orleans$1.4M
- Daniel JohnsonNew Orleans$1M
- Agustin GarciaIndependence$140K
- Mark SidesNew Orleans$11K
- Elizabeth LejeuneLafayette$6K
- Joseph BrierreLafayette$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.